2407. Phase II Study of Avelumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib
Dae-Won Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Tae-Yong Kim, Sae-Won Han, Do-Youn Oh, Seock-Ah Im, Tae-You Kim, Youngeun Lee, Haeryoung Kim, Kyung-Hun Lee
Clinical cancer research, 2020, Epub ahead of printLink
2406. Association of Insulin, Metformin, and Statin with Mortality in Breast Cancer Patients
Mihong Choi, Jiyeon Han, Bo Ram Yang, Myoung-jin Jang, Miso Kim, Dae-Won Lee, Tae-Yong Kim, Seock-Ah Im, Han-Byoel Lee, Hyeong-Gon Moon, Wonshik Han, Dong-Young Noh, Kyung-Hun Lee
Cancer research and treatment, 2020, Epub ahead of printLink
2405. Homologous repair deficiency score for identifying breast cancers with defective DNA damage response
Ahrum Min, Kwangsoo Kim, Kyeonghun Jeong, Seongmin Choi, Seongyeong Kim, Koung Jin Suh, Kyung-Hun Lee, Sun Kim, Seock-Ah Im
2404. Circulating Osteocalcin-Positive Cells as a Novel Diagnostic Biomarker for Bone Metastasis in Breast Cancer Patients
Kyung-Hun Lee, Kyoung Jin Lee, Tae-Yong Kim, Febby Hutomo, Hyun Jin Sun, Gi Jeong Cheon, Serk In Park, Sun Wook Cho, Seock-Ah Im
Journal of bone and mineral research, 2020, 35(10):1838-1849.Link
2403. Therapeutic efficacy of modified anti-miR21 in metastatic prostate cancer.
Kim K, Kim HH, Lee CH, Kim S, Cheon GJ, Kang KW, Chung JK, Youn H.
Biochem Biophys Res Commun. 2020 Aug 27;529(3):707-713.Link
2402. [18F]CB251 PET/MR imaging probe targeting translocator protein (TSPO) independent of its Polymorphism in a Neuroinflammation Model.
Kim K, Kim H, Bae SH, Lee SY, Kim YH, Na J, Lee CH, Lee MS, Ko GB, Kim KY, Lee SH, Song IH, Cheon GJ, Kang KW, Kim SE, Chung JK, Kim EE, Paek SH, Lee JS, Lee BC, Youn H.
2401. Identification of Lymphatic and Hematogenous Routes of Rapidly Labeled Radioactive and Fluorescent Exosomes through Highly Sensitive Multimodal Imaging.
Jung KO, Kim YH, Chung SJ, Lee CH, Rhee S, Pratx G, Chung JK, Youn H.
2400. Induction of leukemic stem cell differentiation by aryl hydrocarbon receptor agonist and synergy with gilteritinib in FLT3-ITD + acute myeloid leukemia
Heejoo Han 1 2, Dong-Yeop Shin 3, Dongchan Kim 1 2, Hyungsuk Kim 4, Chansup Lee 1 5, Youngil Koh 2 3, Junshik Hong 1 2 3, Sung-Soo Yoon 1 3 5
2398. Decreased vitamin C uptake mediated by SLC2A3 promotes leukaemia progression and impedes TET2 restoration
Jun Liu 1, Junshik Hong 2 3 4, Heejoo Han 1, Jihyun Park 1, Dongchan Kim 1, Hyejoo Park 1, Myunggon Ko 5, Youngil Koh 1 6 7, Dong-Yeop Shin 1 6 7, Sung-Soo Yoon 8 9 10